Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pimozide Augmentation for Clozapine Partial Response
NCT00374244Phase 2Completed
- Sponsor
- Yale University
- Start
- Jan 2004
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pimozide in schizophrenia, schizoaffective disorder, sponsored by Yale University. Started Jan 2004; status: completed.
02
Drugs
pimozide
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00374244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374244.